NCT03456791View on ClinicalTrials.gov

Human Epididymis Protein 4 in Endometrial Carcinoma

CompletedOBSERVATIONAL
Enrollment

84

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

June 1, 2018

Study Completion Date

July 30, 2018

Conditions
Endometrial Cancer
Interventions
DIAGNOSTIC_TEST

Human epididymis protein 4

Human epididymis protein will be quantitatively assayed using the enzyme immunometric assay (EIA) method

Trial Locations (1)

Unknown

Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT03456791 - Human Epididymis Protein 4 in Endometrial Carcinoma | Biotech Hunter | Biotech Hunter